Latest News on Sun Pharmaceuticals
Showing of 0 - 10 from 12 results
Sun Pharmaceuticals - Total results - 12
May 06, 2019
Sun Pharma will form ethics panel to supervise corporate governance-related matters: Dilip ShanghviIn January this year, Sun Pharma had announced a slew of measures, including replacement of its domestic formulations distributor Aditya Medisales and change of auditors for its arms.
Apr 12, 2019
Ranbaxy promoters Malvinder, Shivinder Singh diverted funds despite order to maintain stakes, Daiichi Sankyo tells SCThe Supreme Court had earlier expressed displeasure at the replies of Malvinder and Shivinder to its directive to submit a plan for paying Rs 4,000 crore to Daiichi Sankyo, as awarded by a Singapore tribunal.
Mar 14, 2019
SC asks Malvinder Singh and Shivinder Singh to submit concrete plan for paying Rs 3,500 cr to Daiichi SankyoThe Supreme Court on Thursday asked former Ranbaxy promoters Malvinder Singh and Shivinder Singh to submit a concrete plan for paying Rs 3,500 crore to Daiichi Sankyo as directed by a Singapore tribunal
Dec 13, 2018
Sebi examining whistleblower complaint against Sun Pharma, says chairman Ajay TyagiSebi may reopen an insider trading case against Sun Pharma and as well as probe alleged lapses by some of its promoters and other entities in raising funds overseas..
Jul 28, 2016
Sun Pharma to get $50 mn for developing skin disease drug for Spanish firm AlmirallAccording to Sun Pharma, Almirall will be able to lead European studies, and participate in larger Global clinical studies for psoriasis indication subject to the terms of the Sun Pharma - Merck agreements
Dec 31, 2015
Warning letters for pharma cos galore: Now Cadila Healthcare faces USFDA heat, stock tanks 16%The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility
Dec 21, 2015
Sun Pharma shares plunge on USFDA warning letter to its Halol plantFresh warning letter to the company issued on Saturday comes after the facility was first inspected by the US drug regulator in September 2014
Sep 25, 2014
No major surprises: Here are the top 10 of Forbes 100 richest Indians listWhile there are some surprises, many of the usual names made it to the top 10 of the Forbes 100 Richest Indians list. Here's who made it.
Dec 29, 2013
Pharma sector registers single digit growth in 2013; regulators increase scrutinyThe Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of deeper price cuts under pricing policy and selective boycott of companies by the retailers.
Sep 07, 2012
L&T, HUL, Infosys in Forbes list of World's Most Innovative cosTata Consultancy Services (29) with 19.5 percent was fourth among Indian companies with Sun Pharmaceutical Industries (38) with a 14.6 growth bringing up the rear.